Literature DB >> 22708054

Catalytic, Enantioselective Synthesis of Stilbene cis-Diamines: A Concise Preparation of (-)-Nutlin-3, a Potent p53/MDM2 Inhibitor.

Tyler A Davis1, Jeffrey N Johnston.   

Abstract

The first highly diastereo- and enantioselective additions of aryl nitromethane pronucleophiles to aryl aldimines are described. Identification of an electron rich chiral Bis(Amidine) catalyst for this aza-Henry variant was key to this development, leading ultimately to differentially protected cis-stilbene diamines in two steps. This method then became the lynchpin for an enantioselective synthesis of (-)-Nutlin-3 (Hoffmann-LaRoche), a potent cis-imidazoline small molecule inhibitor of p53-MDM2 used extensively as a probe of cell biology and currently in drug development.

Entities:  

Year:  2011        PMID: 22708054      PMCID: PMC3375951          DOI: 10.1039/C1SC00061F

Source DB:  PubMed          Journal:  Chem Sci        ISSN: 2041-6520            Impact factor:   9.825


  33 in total

Review 1.  Small-molecule inhibitors of the p53 suppressor HDM2: have protein-protein interactions come of age as drug targets?

Authors:  Peter M Fischer; David P Lane
Journal:  Trends Pharmacol Sci       Date:  2004-07       Impact factor: 14.819

2.  Metal-catalysed 1,2-diamination reactions.

Authors:  Francesca Cardona; Andrea Goti
Journal:  Nat Chem       Date:  2009-06-22       Impact factor: 24.427

3.  A Novel Bis-Thiourea Organocatalyst for the Asymmetric Aza-Henry Reaction.

Authors:  Constantinos Rampalakos; William D Wulff
Journal:  Adv Synth Catal       Date:  2008-08-04       Impact factor: 5.837

4.  The First Catalytic Asymmetric Nitro-Mannich-Type Reaction Promoted by a New Heterobimetallic Complex.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  1999-12-03       Impact factor: 15.336

5.  Asymmetric catalytic aza-Henry reactions leading to 1,2-diamines and 1,2-diaminocarboxylic acids.

Authors:  Bernhard Westermann
Journal:  Angew Chem Int Ed Engl       Date:  2003-01-13       Impact factor: 15.336

6.  Catalytic Enantioselective Addition of Nitro Compounds to Imines-A Simple Approach for the Synthesis of Optically Active β-Nitro-α-Amino Esters.

Authors:  N Nishiwaki; K Rahbek Knudsen; K V Gothelf; K A Jørgensen
Journal:  Angew Chem Int Ed Engl       Date:  2001       Impact factor: 15.336

Review 7.  Vicinal diamino functionalities as privileged structural elements in biologically active compounds and exploitation of their synthetic chemistry.

Authors:  S R S Saibabu Kotti; Cody Timmons; Guigen Li
Journal:  Chem Biol Drug Des       Date:  2006-02       Impact factor: 2.817

8.  A biomimetic synthesis of thiazolines using hexaphenyloxodiphosphonium trifluoromethanesulfonate.

Authors:  Shu-Li You; Hossein Razavi; Jeffery W Kelly
Journal:  Angew Chem Int Ed Engl       Date:  2003-01-03       Impact factor: 15.336

9.  Highly efficient enantiospecific synthesis of imidazoline-containing amino acids using bis(triphenyl)oxodiphosphonium trifluoromethanesulfonate.

Authors:  Shu-Li You; Jeffery W Kelly
Journal:  Org Lett       Date:  2004-05-13       Impact factor: 6.005

10.  Enantioselective aza-Henry reaction catalyzed by a bifunctional organocatalyst.

Authors:  Tomotaka Okino; Satoru Nakamura; Tomihiro Furukawa; Yoshiji Takemoto
Journal:  Org Lett       Date:  2004-02-19       Impact factor: 6.005

View more
  31 in total

1.  Preparation of (-)-Nutlin-3 using enantioselective organocatalysis at decagram scale.

Authors:  Tyler A Davis; Anna E Vilgelm; Ann Richmond; Jeffrey N Johnston
Journal:  J Org Chem       Date:  2013-10-15       Impact factor: 4.354

2.  Cinchonidinium acetate as a convenient catalyst for the asymmetric synthesis of cis-stilbenediamines.

Authors:  Ryan R Walvoord; Marisa C Kozlowski
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

3.  Enantioselective Synthesis of β-Fluoro Amines via β-Amino α-Fluoro Nitroalkanes and a Traceless Activating Group Strategy.

Authors:  Brandon A Vara; Jeffrey N Johnston
Journal:  J Am Chem Soc       Date:  2016-10-17       Impact factor: 15.419

4.  Enantioselective Addition of Bromonitromethane to Aliphatic N-Boc Aldimines Using a Homogeneous Bifunctional Chiral Organocatalyst.

Authors:  Kenneth E Schwieter; Jeffrey N Johnston
Journal:  ACS Catal       Date:  2015       Impact factor: 13.084

5.  Methods for direct alkene diamination, new & old.

Authors:  Sam de Jong; Daniel G Nosal; Duncan J Wardrop
Journal:  Tetrahedron       Date:  2012-03-21       Impact factor: 2.457

6.  Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease.

Authors:  Mark C Dobish; Fernando Villalta; Michael R Waterman; Galina I Lepesheva; Jeffrey N Johnston
Journal:  Org Lett       Date:  2012-12-07       Impact factor: 6.005

7.  Development of an Intermittent-Flow Enantioselective Aza-Henry Reaction Using an Arylnitromethane and Homogeneous Brønsted Acid-Base Catalyst with Recycle.

Authors:  Sergey V Tsukanov; Martin D Johnson; Scott A May; Morgan Rosemeyer; Michael A Watkins; Stanley P Kolis; Matthew H Yates; Jeffrey N Johnston
Journal:  Org Process Res Dev       Date:  2016-02-01       Impact factor: 3.317

8.  Palladium-catalyzed nitromethylation of aryl halides: an orthogonal formylation equivalent.

Authors:  Ryan R Walvoord; Simon Berritt; Marisa C Kozlowski
Journal:  Org Lett       Date:  2012-07-27       Impact factor: 6.005

9.  Minimizing the amount of nitromethane in palladium-catalyzed cross-coupling with aryl halides.

Authors:  Ryan R Walvoord; Marisa C Kozlowski
Journal:  J Org Chem       Date:  2013-08-13       Impact factor: 4.354

10.  Organocatalytic, diastereo- and enantioselective synthesis of nonsymmetric cis-stilbene diamines: a platform for the preparation of single-enantiomer cis-imidazolines for protein-protein inhibition.

Authors:  Brandon A Vara; Anand Mayasundari; John C Tellis; Michael W Danneman; Vanessa Arredondo; Tyler A Davis; Jaeki Min; Kristin Finch; R Kiplin Guy; Jeffrey N Johnston
Journal:  J Org Chem       Date:  2014-07-14       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.